Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,659
archived clinical trials in
Metabolic

Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Saint Thomas Hospital
1759
mi
from 91732
Nashville, TN
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Saint Thomas Hospital
1759
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Baylor University Medical Center
1225
mi
from 91732
Dallas, TX
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Baylor University Medical Center
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Cardiopulmonary Research Science & Technology Institute
1224
mi
from 91732
Dallas, TX
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Cardiopulmonary Research Science & Technology Institute
1224
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Baptist Hospital Downtown
1189
mi
from 91732
San Antonio, TX
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Baptist Hospital Downtown
1189
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Renal Associates, PA
1188
mi
from 91732
San Antonio, TX
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Renal Associates, PA
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Clinical Research and Consulting Centter
2268
mi
from 91732
Fairfax, VA
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Clinical Research and Consulting Centter
2268
mi
from 91732
Fairfax, VA
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Sentara Norfolk General Hospital
2336
mi
from 91732
Norfolk, VA
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Sentara Norfolk General Hospital
2336
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
VCU Medical Center
2269
mi
from 91732
Richmond, VA
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
VCU Medical Center
2269
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
VCU Medical Center
2269
mi
from 91732
Richmond, VA
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
VCU Medical Center
2269
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Camc Institute
2038
mi
from 91732
Charleston, WV
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Camc Institute
2038
mi
from 91732
Charleston, WV
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Sarah S Olelewe MD
21
mi
from 91732
Hawthorne, CA
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Sarah S Olelewe MD
21
mi
from 91732
Hawthorne, CA
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Progressive Clinical Research
75
mi
from 91732
Vista, CA
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Progressive Clinical Research
75
mi
from 91732
Vista, CA
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Pikes Peak Cardiology
802
mi
from 91732
Colorado Springs, CO
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Pikes Peak Cardiology
802
mi
from 91732
Colorado Springs, CO
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Innovative Research of West FL
2117
mi
from 91732
Largo, FL
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Innovative Research of West FL
2117
mi
from 91732
Largo, FL
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Coastal Nephrology Assoc. Research Center
2180
mi
from 91732
Punta Gorda, FL
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Coastal Nephrology Assoc. Research Center
2180
mi
from 91732
Punta Gorda, FL
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Rockdale Medical Research Associates
1940
mi
from 91732
Conyers, GA
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Rockdale Medical Research Associates
1940
mi
from 91732
Conyers, GA
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Otis Barnum, DO
1450
mi
from 91732
Natchitoches, LA
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Otis Barnum, DO
1450
mi
from 91732
Natchitoches, LA
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Lillestol Research LLC
1414
mi
from 91732
Fargo, ND
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Lillestol Research LLC
1414
mi
from 91732
Fargo, ND
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Carolina Research Associates
2099
mi
from 91732
Columbia, SC
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Carolina Research Associates
2099
mi
from 91732
Columbia, SC
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Wayne O. Wells, MD
1788
mi
from 91732
Lebanon, TN
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Wayne O. Wells, MD
1788
mi
from 91732
Lebanon, TN
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Memorial Clinical Associates
1346
mi
from 91732
Houston, TX
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Memorial Clinical Associates
1346
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated:  4/26/2011
Mitchell Rosner, MD
2207
mi
from 91732
Charlottesville, VA
Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients
A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients
Status: Enrolling
Updated: 4/26/2011
Mitchell Rosner, MD
2207
mi
from 91732
Charlottesville, VA
Click here to add this to my saved trials
Comparison of Meal Replacements Versus Protein Supplements and Utilizing the Protein Digestibility Corrected Amino Acid Score (PDCAAS) Method
Comparison of Meal Replacements Versus Protein Supplements and Utilizing the PDCAAS Method in the Bariatric Patient
Status: Enrolling
Updated:  7/22/2011
Southeast Bariatrics
2102
mi
from 91732
Charlotte, NC
Comparison of Meal Replacements Versus Protein Supplements and Utilizing the Protein Digestibility Corrected Amino Acid Score (PDCAAS) Method
Comparison of Meal Replacements Versus Protein Supplements and Utilizing the PDCAAS Method in the Bariatric Patient
Status: Enrolling
Updated: 7/22/2011
Southeast Bariatrics
2102
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
A Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase®
A Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System Involvement and Who Are Currently Receiving Treatment With Elaprase®
Status: Enrolling
Updated:  10/6/2011
University of North Carolina at Chapel Hill
2189
mi
from 91732
Chapel Hill, NC
A Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase®
A Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System Involvement and Who Are Currently Receiving Treatment With Elaprase®
Status: Enrolling
Updated: 10/6/2011
University of North Carolina at Chapel Hill
2189
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome
A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome
Status: Enrolling
Updated:  2/27/2012
Wvu Department of Pediatrics
2036
mi
from 91732
Charleston, WV
A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome
A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome
Status: Enrolling
Updated: 2/27/2012
Wvu Department of Pediatrics
2036
mi
from 91732
Charleston, WV
Click here to add this to my saved trials
Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease
An Open-Label, Dose Escalation With 2 Dose Levels, Proof-of-Concept Clinical Trial of Ambroxol for the Treatment of Type I Gaucher Disease
Status: Enrolling
Updated:  3/1/2012
ExSAR Corporation
2405
mi
from 91732
Monmouth Junction, NJ
Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease
An Open-Label, Dose Escalation With 2 Dose Levels, Proof-of-Concept Clinical Trial of Ambroxol for the Treatment of Type I Gaucher Disease
Status: Enrolling
Updated: 3/1/2012
ExSAR Corporation
2405
mi
from 91732
Monmouth Junction, NJ
Click here to add this to my saved trials
Biotin Status in Pregnancy
Biotin Status in Pregnancy
Status: Enrolling
Updated:  7/24/2012
University of Arkansas for Medical Sciences
1461
mi
from 91732
Little Rock, AR
Biotin Status in Pregnancy
Biotin Status in Pregnancy
Status: Enrolling
Updated: 7/24/2012
University of Arkansas for Medical Sciences
1461
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated:  8/27/2012
Clinical Research Facility
2187
mi
from 91732
Daytona Beach, FL
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated: 8/27/2012
Clinical Research Facility
2187
mi
from 91732
Daytona Beach, FL
Click here to add this to my saved trials
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated:  8/27/2012
Clinical Research Facility
1924
mi
from 91732
Decatur, GA
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated: 8/27/2012
Clinical Research Facility
1924
mi
from 91732
Decatur, GA
Click here to add this to my saved trials
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated:  8/27/2012
Clinical Research Facility
1932
mi
from 91732
Ann Arbor, MI
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated: 8/27/2012
Clinical Research Facility
1932
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated:  8/27/2012
Clinical Research Facility
2423
mi
from 91732
Newark, NJ
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated: 8/27/2012
Clinical Research Facility
2423
mi
from 91732
Newark, NJ
Click here to add this to my saved trials
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated:  8/27/2012
Clinical Research Facility
2435
mi
from 91732
New York, NY
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated: 8/27/2012
Clinical Research Facility
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated:  8/27/2012
Clinical Research Facility
2336
mi
from 91732
Norfolk, VA
A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta
Evaluation of Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta (The Inform Study)
Status: Enrolling
Updated: 8/27/2012
Clinical Research Facility
2336
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
Quick Start Insertion of Mirena and ParaGard
Quick Start Insertion of Mirena and ParaGard Intrauterine Contraceptive Devices
Status: Enrolling
Updated:  11/20/2012
Columbia University Medical Center
2432
mi
from 91732
New York, NY
Quick Start Insertion of Mirena and ParaGard
Quick Start Insertion of Mirena and ParaGard Intrauterine Contraceptive Devices
Status: Enrolling
Updated: 11/20/2012
Columbia University Medical Center
2432
mi
from 91732
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia
Status: Enrolling
Updated:  11/27/2012
Biofortis Clinical Research
1711
mi
from 91732
Addison, IL
Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia
Status: Enrolling
Updated: 11/27/2012
Biofortis Clinical Research
1711
mi
from 91732
Addison, IL
Click here to add this to my saved trials
Effect of Tolvaptan on Cognitive Function in Cirrhosis
Effects of Tolvaptan on Cognitive Function, Brain Metabolism and Quality of Life in Hyponatremic Cirrhotics With Hepatic Encephalopathy: A Prospective Clinical Trial
Status: Enrolling
Updated:  12/10/2012
Hunter Holmes McGuire VA Medical Center
2265
mi
from 91732
Richmond, VA
Effect of Tolvaptan on Cognitive Function in Cirrhosis
Effects of Tolvaptan on Cognitive Function, Brain Metabolism and Quality of Life in Hyponatremic Cirrhotics With Hepatic Encephalopathy: A Prospective Clinical Trial
Status: Enrolling
Updated: 12/10/2012
Hunter Holmes McGuire VA Medical Center
2265
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Vitamin D for Painful Nocturnal Leg Cramps
Nocturnal Leg Cramps in the Elderly: Randomized Controlled Trial of Ergocalciferol (Vitamin D2) for a Painful and Distressing Problem
Status: Enrolling
Updated:  1/14/2013
University of Wisconsin
1654
mi
from 91732
Madison, WI
Vitamin D for Painful Nocturnal Leg Cramps
Nocturnal Leg Cramps in the Elderly: Randomized Controlled Trial of Ergocalciferol (Vitamin D2) for a Painful and Distressing Problem
Status: Enrolling
Updated: 1/14/2013
University of Wisconsin
1654
mi
from 91732
Madison, WI
Click here to add this to my saved trials
Oral N-acetylcysteine for the Treatment of Parkinson's Disease
Oral N-acetylcysteine for the Treatment of Parkinson's Disease
Status: Enrolling
Updated:  1/14/2013
Univ of Minnesota
1511
mi
from 91732
Minneapolis, MN
Oral N-acetylcysteine for the Treatment of Parkinson's Disease
Oral N-acetylcysteine for the Treatment of Parkinson's Disease
Status: Enrolling
Updated: 1/14/2013
Univ of Minnesota
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
Unrecognized Mucopolysaccharidosis I, II, IVA, and VI in the Pediatric Rheumatology Population
Status: Enrolling
Updated:  2/5/2013
University of Medicine and Dentistry of New Jersey
2423
mi
from 91732
Newark, NJ
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
Unrecognized Mucopolysaccharidosis I, II, IVA, and VI in the Pediatric Rheumatology Population
Status: Enrolling
Updated: 2/5/2013
University of Medicine and Dentistry of New Jersey
2423
mi
from 91732
Newark, NJ
Click here to add this to my saved trials
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
Unrecognized Mucopolysaccharidosis I, II, IVA, and VI in the Pediatric Rheumatology Population
Status: Enrolling
Updated:  2/5/2013
Hospital for Special Surgery
2434
mi
from 91732
New York, NY
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
Unrecognized Mucopolysaccharidosis I, II, IVA, and VI in the Pediatric Rheumatology Population
Status: Enrolling
Updated: 2/5/2013
Hospital for Special Surgery
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Lovaza Mechanisms of Action
Study of the Effects of Lovaza (Omega 3 Fatty Acids) On Lipoprotein Particles and Their Transcriptional Effects
Status: Enrolling
Updated:  2/21/2013
Brigham and Women's Hosp
2578
mi
from 91732
Boston, MA
Lovaza Mechanisms of Action
Study of the Effects of Lovaza (Omega 3 Fatty Acids) On Lipoprotein Particles and Their Transcriptional Effects
Status: Enrolling
Updated: 2/21/2013
Brigham and Women's Hosp
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Status: Enrolling
Updated:  2/28/2013
Children's Hospital and Research Center
352
mi
from 91732
Oakland, CA
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Status: Enrolling
Updated: 2/28/2013
Children's Hospital and Research Center
352
mi
from 91732
Oakland, CA
Click here to add this to my saved trials
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Status: Enrolling
Updated:  2/28/2013
Univ of Minnesota
1511
mi
from 91732
Minneapolis, MN
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
An Observational Prospective Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
Status: Enrolling
Updated: 2/28/2013
Univ of Minnesota
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated:  3/25/2013
Otsuka Investigational Site
1784
mi
from 91732
Huntsville, AL
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated: 3/25/2013
Otsuka Investigational Site
1784
mi
from 91732
Huntsville, AL
Click here to add this to my saved trials
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated:  3/25/2013
Otsuka Investigational Site
7
mi
from 91732
Azusa, CA
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated: 3/25/2013
Otsuka Investigational Site
7
mi
from 91732
Azusa, CA
Click here to add this to my saved trials
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated:  3/25/2013
Otuska Investigational Site
21
mi
from 91732
Orange, CA
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated: 3/25/2013
Otuska Investigational Site
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated:  3/25/2013
Otsuka Investigational Site
817
mi
from 91732
Denver, CO
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated: 3/25/2013
Otsuka Investigational Site
817
mi
from 91732
Denver, CO
Click here to add this to my saved trials
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated:  3/25/2013
Otsuka Investigational Site
2345
mi
from 91732
Newark, DE
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated: 3/25/2013
Otsuka Investigational Site
2345
mi
from 91732
Newark, DE
Click here to add this to my saved trials
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated:  3/25/2013
Otsuka Investigational Site
2281
mi
from 91732
Washington,
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated: 3/25/2013
Otsuka Investigational Site
2281
mi
from 91732
Washington,
Click here to add this to my saved trials
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated:  3/25/2013
Otsuka Investigational Site
2130
mi
from 91732
Jacksonville, FL
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Phase 3b, Multicenter, Randomized, Single-blind, Parallel Group Trial of the Effects of Titrated Oral SAMSCA(r) (Tolvaptan) 15, 30, or 60 mg QD Compared to Placebo Plus Fluid Restriction on Length of Hospital Stay and Symptoms in Subjects Hospitalized With Dilutional Hyponatremia
Status: Enrolling
Updated: 3/25/2013
Otsuka Investigational Site
2130
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials